 |
- Last updated refers to the date when our listing for each treatment was last updated.
- ID is our internal ID - starting with VT.
- Min Karnofsky is a general guide to how well you have to function to use this treatment
- For trials that also have a NCT number, you can click that number to pop up the listing from the clinicaltrials.gov website.
|
|
|
|
|
|
Treatment Name: |
|
A Feasibility Assessment and a Phase I/II Trial of MLN518 (Tandutinib) for Treatment of Patients with Recurrent Glioblastoma |
|
|
|
|
|
|
Keywords: |
|
Tandutinib |
|
|
|
|
Phase: |
|
Phase 1/2 |
|
|
|
|
|
|
Treatment ID#s: |
|
VT1766
NCT00379080
|
|
|
|
|
Age Group: |
|
Adults Only |
|
|
|
|
|
|
Min Karnofsky Score: |
|
60: Requires occasional assistance but is able to care for most of own needs |
|
|
|
|
Conditions: |
|
Newly Diagnosed: N
Recurrent: Y
Prior Surgery is Allowed
Prior Radiation is Allowed
Prior Chemotherapy is Allowed
|
|
|
|
|
|
|
Last Updated: |
|
04/21/2009 |
|
|
|
|
Tumor Types: |
|
Glioblastoma Multiforme |
|
|
|
|
|
|
|
Comments: |
|
RATIONALE: Tandutinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. |
|
|
|
|
|
|
Treatment Type: |
|
Less-Toxics
Immunological, Biological or Targeted Therapy. |
|
|
|
|
Contact: |
|
Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham
Clinical Trials Office - University of Alabama at Birmingham
Birmingham, AL 35294
Phone:205-934-0309
Email not available
H. Lee Moffitt Cancer Center and Research Institute
Steven Brem, MD
Program Leader, Neuro Oncology
12902 Magnolia Drive Suite 3136
MCC-NEURPROG
Tampa, FL 33612
Phone:813-979-3056
Fax: 813-903-7139
Click here to send an email
Website: www.moffitt.usf.edu/Prevention_and_Treatment/clinical_programs/nonc/
Emory University
Jeffrey Olsen
Contact: Dr. Jeffrey Olsen
1327 Clifton Road, NE
Atlanta, GA 30322-
Phone:(404)778-5344
Fax: (404)778-5121
Click here to send an email
Mass. General Hospital - Brain Tumor Center
Tracy Batchelor, MD, MPH
Executive Director
Brain Tumor Center
Suite 315, Cox Building
Boston, MA 02114
Phone:617-724-8770
Fax: (617)724-8769
Click here to send an email
Website: brain.mgh.harvard.edu
Johns Hopkins Hospital
Stuart Grossman, MD
Professor of Oncology, Medicine & Neurosurgery
Contact: Stuart Grossman
Bunting & Blaustein Cancer Research Bldg
1650 Orleans Street
Baltimore, MD 21231-1000
Phone:(410)955-8837
Fax: 410-614-9335
Click here to send an email
Website: www.nabtt.org/johns.html
National Cancer Institute
NCI
Cheryl Royce, CRNP, Clinical Director
Neuro-oncology Branch
9030 Old Georgetown Road
Bethesda, MD 20892
Phone:866-251-9686
Click here to send an email
Website: home.ccr.cancer.gov/nob/
Henry Ford Hospital
Tom MikKelsen, MD, FRCP(C)
Co-Director
Contact: Dr. Tom Mikelsen
Hermelin Brain Tumor Center
E&R3096 Henry Ford Hospital 2799 West Grand Blvd
Detroit, MI 48202-
Phone:313 916-8641
Fax: 313 916-9855
Click here to send an email
Website: www.nabtt.org/henry.html
Wake Forest Comprehensive Cancer Center
Judy Lovelace, R.N.
Medical Oncology
Medical Center Blvd.
Winston-Salem, NC 27157
Phone:336-716-6759
Fax: ( ) -
Click here to send an email
Website: www.bgsm.edu/bgsm/surg-sci/ns/btprotocols.html
Cleveland Clinic Brain Tumor and Neuro-Oncology Center
Gene Barnett, M.D.
Professor and Chairman Brain Tumor Institute
R20
9500 Euclid Ave.
Cleveland, OH 44195
Phone:216-445-1379
Fax: 216-444-0924
Click here to send an email
Website: ccf.org
Abramson Cancer Center
Clinical Trials Office - Abramson Cancer Center
University of Pennsylvania
Philadelphia, PA 19104
Phone:800-474-9892
Email not available |
|
|
|
|
